Get started
Author

Margeaux Hodgson‐Garms

Observed names: HODGSON-GARMS, MARGEAUX, Hodgson-Garms, Margeaux, M. Hodgson-Garms, Margeaux Hodgson-Garms
Observed institutions: La Trobe University, Australian Regenerative Medicine Institute, Max Planck Institute for Medical Research, Olivia Newton-John Cancer Wellness & Research Centre, Olivia Newton-John Cancer Research Institute, Monash University
ORCID: 0009-0006-1354-6987
Observed ORCID: 0009-0006-1354-6987
OpenAlex ID: A5113323865
Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming
2017 · Xiaodong Liu, Christian M Nefzger, et al. · Nature Methods · 171
PDF
Multiplicity of Mesenchymal Stromal Cells: Finding the Right Route to Therapy
2019 · Alison Wilson, Margeaux Hodgson-Garms, et al. · Frontiers in Immunology · 125
PDF
Precision Surface Microtopography Regulates Cell Fate via Changes to Actomyosin Contractility and Nuclear Architecture
2021 · James Carthew, Hazem H. Abdelmaksoud, et al. · Advanced Science · 86
PDF
Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing
2025 · Margeaux Hodgson-Garms, Matthew J. Moore, et al. · npj Regenerative Medicine · 44
PDF
Substrate mechanical properties bias MSC paracrine activity and therapeutic potential
2023 · Aeolus Vilar, Margeaux Hodgson-Garms, et al. · Acta Biomaterialia · 38
Next Generation Cell Culture Tools Featuring Micro‐ and Nanotopographies for Biological Screening
2021 · James Carthew, Hazem H. Abdelmaksoud, et al. · Advanced Functional Materials · 32
PDF
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
2022 · Andrew J. Weickhardt, David K. Lau, et al. · BMC Cancer · 21
PDF
Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness
2024 · Amlan Chakraborty, Chao Wang, et al. · Biomedicine & Pharmacotherapy · 16
Next Generation Cell Culture Tools Featuring Micro‐ and Nanotopographies for Biological Screening (Adv. Funct. Mater. 3/2022)
2022 · James Carthew, Hazem H. Abdelmaksoud, et al. · Advanced Functional Materials · 1
Dual targeting of FGFR3 and the ERBB receptor family or AXL enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
2021 · David Lau, Margeaux Hodgson-Garms, et al. · Research Square · 1
PDF
Nanoscale Imaging and Proteomic Analysis Reveal a Tightly Regulated, Amorphous Granular Biopolymer Structure inside Bacteria
2026 · Edward Attenborough, Kevin H. Putera, et al. · ACS Biomaterials Science & Engineering
PDF
Mesenchymal Stem/Stromal Cells: Late Breaking Abstract: A COMPARITIVE ANALYSIS OF THE MSC SECRETOME: HUMAN IPSC-DERIVED MSCS AND THEIR TISSUE-DERIVED COUNTERPARTS
2022 · M. Hodgson-Garms, M. Martino, et al. · Cytotherapy
Comparitive analysis of MSC heterogenity: iPSC-derived mscs and their tissue- derived counterparts
2021 · M. Hodgson-Garms, M. Martino, et al. · Cytotherapy
Mechanisms of acquired resistance to the fibroblast growth factor receptor (FGFR) inhibitor BGJ398 in FGFR driven bladder cancer
2016 · M. Hodgson-Garms, J. Mariadason, et al. · Annals of Oncology
Works count: 18
Citation count: 535
H-index: 8
I10-index: 8
Year
Topic
Type